North Star Investment Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
CI
North Star Investment Management's PJP Position: Q1 2026 in Review
North Star Investment Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 600 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #683.
North Star Investment Management first reported a position in PJP in Q4 2019 and has held it in 26 quarters since. The position peaked at $62.7K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- North Star Investment Management held 600 shares of Invesco Pharmaceuticals ETF worth $62.3K as of Q1 2026.
- North Star Investment Management left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #683 holding.
- North Star Investment Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 26 quarters since.
- North Star Investment Management's Invesco Pharmaceuticals ETF position peaked at $62.7K in Q4 2025.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.